And guys would benefit from paying attention to their skin cancer risk. “The truth is that, in aggregate, men just don’t take ...

Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...

Douglas Adkins, MD, discusses future directions of the KEYNOTE-689 trial of pembrolizumab in head and neck cancer following the agent's FDA approval.

Fred Hutch announces eight recipients of the 2025 Dr. Eddie Méndez Scholar Award, which honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science.

Cancer treatment times are being tackled in south Essex in a bid to provide "highest possible quality of care" after alarming new ...

Weight loss is something we are all aware of and many of us have also gone through the process ourselves. While it may seem like a simple concept, it can affect us all differently. Turmeric is a spice ...

Following a successful launch of Phase 2 clinical trials in March, HanchorBio Inc., a pioneer of immunotherapy biologics, is announcing interim data for a concurrent Phase 1b dose-escalation trial ...

A popular California-based doctor has cautioned against three highly toxic things in your bedroom that could be causing ...

Globally, women are roughly twice as likely as men to be diagnosed with thyroid cancer. However, recent research shows that ...